Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Exanthema 1 Diarrhea 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

ceterizine hydrochloride 1 capivasertib 1 Standard of Care 1 Loperamide 1 Fulvestrant 1 Fecal Microbiota Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Diarrhea × capivasertib × Clear all

NCT07426822 2026-02-24

SAFE-CAP

Yale University

Phase 2 Not yet recruiting

Diarrhea, Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡